Comparison of the VersaTREK system and Lowenstein-Jensen medium for the recovery of mycobacteria from clinical specimens

被引:6
作者
Falconi, Francisco Quinones [2 ]
Suarez, Lourdes Infante [2 ]
Castillejos Lopez, Manuel de Jesus [1 ]
Sancho, Cecilia Garcia [1 ]
机构
[1] Inst Nacl Enfermedades Resp, Dept Invest TB, Mexico City, DF, Mexico
[2] Inst Nacl Enfermedades Resp, Serv Microbiol Clin, Mexico City, DF, Mexico
关键词
D O I
10.1080/00365540701522967
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Laboratory services for the detection of tuberculosis form an essential component of the DOTS strategy. Our objective was to evaluate the recovery rate and mean time to detection (TTD) of mycobacteria of 2 culture media: the VersaTREK system and the Lowenstein-Jensen medium (LJ). Clinical specimens were processed using the standard N-acetyl-L- cysteine (NALC)-NaOH method, and then inoculated onto VersaTREK system and LJ slants. Of 1510 specimens cultured, a total of 200 mycobacterial isolates (159 Mycobacterium tuberculosis and 41 no M. tuberculosis mycobacteria) were detected. The recovery rates were 84.8% (168/198) for the VersaTREK system and 89.4% (168/188) for LJ (p = 0.2); while the contamination rates were 4.2% for the VersaSATREK system and 7.4% for LJ (p < 0.001). The TTDs for mycobacteria spp. were 18.2 ( +/- 11.4) d for the VersaTREK system and 27.9 (+/- 10.9) d for LJ (p < 0.001). The TTDs for M. tuberculosis were 19.8 (+/- 11.2) d for the VersaTREK system and 27.3 (+/- 10.2) d for LJ (p < 0.001). The difference in TTD between smear-positive and smear-negative specimens for Mycobacterium spp. was 15.9 (+/- 10.0) vs 23.0 (+/- 12.5) d, and for M. tuberculosis 16.7 (+/- 9.5) vs 28.4 (+/- 11.1) d for the VersaTREK system. The VersaTREK system significantly reduces the TTDs of mycobacteria detection, which is clinically relevant.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 16 条
[1]  
Alcaide F, 2000, J CLIN MICROBIOL, V38, P398
[2]  
Chien HP, 2000, INT J TUBERC LUNG D, V4, P866
[3]   Diagnostic standards and classification of tuberculosis in adults and children [J].
Dunlap, NE ;
Bass, J ;
Fujiwara, P ;
Hopewell, P ;
Horsburgh, CR ;
Salfinger, M ;
Simone, PM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1376-1395
[4]  
Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1
[5]  
GULLANS CR, 1992, CLIN MICROBIOLOGY PR, V1
[6]   Laboratory diagnosis of mycobacterial infections: New tools and lessons learned [J].
Hale, YM ;
Pfyffer, GE ;
Salfinger, M .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) :834-846
[7]  
Ito Kunihiko, 2006, Kekkaku, V81, P401
[8]  
Metchock BG., 1999, Manual of clinical microbiologyx. Dans: Mycobacterium, V7th ed, P399
[9]  
Somoskövi A, 2000, J CLIN MICROBIOL, V38, P2395
[10]  
*TREK, 2006, TREK DIAGN SYST MAGE